{"date":"2025-03-18","count":41,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6610-2025-03-18-2205-lga4g4","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"22:05:47","subject":"公告本公司113年度現金增資認股基準日暨相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-03-18 22:05，「公告本公司113年度現金增資認股基準日暨相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-03-18-2159-1doi6ae","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"21:59:56","subject":"公告金融監督管理委員同意本公司申請延長113年度現金增資發行新股募集期間","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-03-18 21:59，「公告金融監督管理委員同意本公司申請延長113年度現金增資發行新股募集期間」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-18-1941-monwha","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"19:41:30","subject":"公告本公司董事會通過113年度董事及員工酬勞分配案","clause":"第44款","fact_date":"2025-03-18","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-18 19:41，「公告本公司董事會通過113年度董事及員工酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-18-1925-1v5vq5h","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"19:25:07","subject":"公告本公司董事會通過113年度合併財務報告公告","clause":"第43款","fact_date":"2025-03-18","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-18 19:25，「公告本公司董事會通過113年度合併財務報告公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-18-1917-7l9f4u","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"19:17:43","subject":"公告本公司董事會決議召開113年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-18 19:17，「公告本公司董事會決議召開113年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-03-18-1857-sipkdd","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"18:57:15","subject":"公告本公司經主管機關核准撤銷113年第一次現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-03-18 18:57，「公告本公司經主管機關核准撤銷113年第一次現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-18-1851-1orm707","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"18:51:06","subject":"公告本公司董事會決議盈餘暨資本公積轉增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-18 18:51，「公告本公司董事會決議盈餘暨資本公積轉增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-18-1827-m2cx8b","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"18:27:09","subject":"公告本公司董事會通過會計主管追認案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-18 18:27，「公告本公司董事會通過會計主管追認案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-18-1813-11wjw0o","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"18:13:40","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-18 18:13，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-03-18-1758-1f58f2d","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"17:58:53","subject":"公告本公司今日接獲註冊代理人通知，阿聯酋衛生局(MOHAP)受理Bonvadis外用乳膏醫材產品註冊申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-03-18 17:58，「公告本公司今日接獲註冊代理人通知，阿聯酋衛生局(MOHAP)受理Bonvadis外用乳膏醫材產品註冊申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-18-1737-u5r96g","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"17:37:53","subject":"本公司董事會決議購置廠房及建置裝潢案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-18 17:37，「本公司董事會決議購置廠房及建置裝潢案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-03-18-1655-lfu7y6","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"16:55:40","subject":"本公司受邀參加群益金鼎證券2025年第一季投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-03-18 16:55，「本公司受邀參加群益金鼎證券2025年第一季投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-03-18-1654-bwopfv","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"16:54:01","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2025-03-18","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-03-18 16:54，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-03-18-1653-1v1wt8s","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-03-18","time":"16:53:56","subject":"公告本公司取得會計師113年度內部控制專案審查報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-03-18 16:53，「公告本公司取得會計師113年度內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-03-18-1652-1psozu8","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"16:52:02","subject":"代子公司公告「METHODS FOR TREATING OCULAR DISEASES用於治療眼疾的方法」取得歐洲發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-03-18 16:52，「代子公司公告「METHODS FOR TREATING OCULAR DISEASES用於治療眼疾的方法」取得歐洲發明專」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-03-18-1643-1pb8ufa","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"16:43:56","subject":"公告本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-03-18 16:43，「公告本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-03-18-1622-1o1wvf4","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"16:22:37","subject":"本公司董事會決議發行114年度限制員工權利新股案。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-03-18 16:22，「本公司董事會決議發行114年度限制員工權利新股案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-03-18-1621-936kpr","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"16:21:52","subject":"公告本公司董事會決議114年度員工認股權憑證發行及認股辦法。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-03-18 16:21，「公告本公司董事會決議114年度員工認股權憑證發行及認股辦法。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2025-03-18-1621-e2by5t","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"16:21:34","subject":"本公司受邀參加由德信證券舉辦之2025年第一季法人說明會","clause":"第30款","fact_date":"2025-03-19","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2025-03-18 16:21，「本公司受邀參加由德信證券舉辦之2025年第一季法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-03-18-1621-5z2zht","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"16:21:20","subject":"公告本公司董事會決議召開民國114年股東常會相關事宜。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-03-18 16:21，「公告本公司董事會決議召開民國114年股東常會相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-03-18-1619-1lnd450","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"16:19:09","subject":"公告本公司董事會通過民國113年度個別財務報告","clause":"第43款","fact_date":"2025-03-18","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-03-18 16:19，「公告本公司董事會通過民國113年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-03-18-1600-72zcj7","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-03-18","time":"16:00:12","subject":"公告本公司與Cipla Limited簽署眼部術後炎症和疼痛治療新藥APP13007於印度、東南亞、非洲和南美洲市場共11國之獨家授權合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-03-18 16:00，「公告本公司與Cipla Limited簽署眼部術後炎症和疼痛治療新藥APP13007於印度、東南亞、非洲和南美洲市場共1」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-03-18-1548-onlkkr","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"15:48:48","subject":"公告本公司董事會決議不分派股利。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-03-18 15:48，「公告本公司董事會決議不分派股利。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-03-18-1547-5l8j71","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"15:47:21","subject":"公告本公司受邀參加統一證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-03-18 15:47，「公告本公司受邀參加統一證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-03-18-1540-1ctgck9","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"15:40:48","subject":"本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-03-18 15:40，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-03-18-1540-1njisnr","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"15:40:24","subject":"本公司董事會決議113年度限制員工權利新股發行增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-03-18 15:40，「本公司董事會決議113年度限制員工權利新股發行增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-03-18-1539-cievxs","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"15:39:51","subject":"本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-03-18 15:39，「本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-03-18-1538-1stc4f8","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"15:38:59","subject":"本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-03-18 15:38，「本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-03-18-1538-1xud6su","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"15:38:33","subject":"本公司董事會決議通過113年度財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-03-18 15:38，「本公司董事會決議通過113年度財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-03-18-1537-lfgi2r","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"15:37:36","subject":"公告本公司董事會通過113年度合併財務報告。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-03-18 15:37，「公告本公司董事會通過113年度合併財務報告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6580-2025-03-18-1536-jigmxb","company_id":"6580","company":"台睿","market":"興櫃","industry":"生技醫療","date":"2025-03-18","time":"15:36:37","subject":"公告本公司董事會通過113年度個體財務報告。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台睿（6580），2025-03-18 15:36，「公告本公司董事會通過113年度個體財務報告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-03-18-1457-dg44ap","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"14:57:14","subject":"代本公司之重要子公司威茂(股)公司公告董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-03-18 14:57，「代本公司之重要子公司威茂(股)公司公告董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-03-18-1451-4kwcbi","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"14:51:24","subject":"代本公司之重要子公司威茂(股)公司公告董事會代行股東會通過解除董事競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-03-18 14:51，「代本公司之重要子公司威茂(股)公司公告董事會代行股東會通過解除董事競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-03-18-1445-1y5fuet","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"14:45:31","subject":"代本公司之重要子公司威茂(股)公司公告114年董事會代行股東會選任董事及監察人當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-03-18 14:45，「代本公司之重要子公司威茂(股)公司公告114年董事會代行股東會選任董事及監察人當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-18-1433-1i3ktnz","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"14:33:53","subject":"代重要子公司鼎晉生技股份有限公司公告董事會決議全面換發無實體股票","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-18 14:33，「代重要子公司鼎晉生技股份有限公司公告董事會決議全面換發無實體股票」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-18-1433-c9peqm","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"14:33:12","subject":"代重要子公司鼎晉生技股份有限公司公告董事會通過辦理股票公開發行暨申請登錄興櫃","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-18 14:33，「代重要子公司鼎晉生技股份有限公司公告董事會通過辦理股票公開發行暨申請登錄興櫃」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-18-1432-1t1ku6c","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"14:32:29","subject":"代重要子公司鼎晉生技股份有限公司公告董事會決議召開民國114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-18 14:32，「代重要子公司鼎晉生技股份有限公司公告董事會決議召開民國114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-18-1431-1ri5un1","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"14:31:41","subject":"代重要子公司鼎晉生技股份有限公司公告董事會決議解除經理人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-18 14:31，「代重要子公司鼎晉生技股份有限公司公告董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-18-1431-1dcn7ls","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"14:31:02","subject":"代重要子公司鼎晉生技股份有限公司公告董事會決議113年度不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-18 14:31，「代重要子公司鼎晉生技股份有限公司公告董事會決議113年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-18-1430-1hjd8eu","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"14:30:11","subject":"代重要子公司鼎晉生技股份有限公司公告董事會推選王慧君博士擔任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-18 14:30，「代重要子公司鼎晉生技股份有限公司公告董事會推選王慧君博士擔任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-03-18-1342-7ammwo","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-03-18","time":"13:42:03","subject":"公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSAND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVESN」馬來西亞專利核准通知書。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-03-18 13:42，「公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSAND CRYSTALLINE F」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}